Open access
65
Views
10
CrossRef citations to date
0
Altmetric
Original Research
Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study
Shu Hashimoto1 Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, JapanCorrespondence[email protected]
, Hisataro Ikeuchi2 Novartis Pharma KK, Minato-ku, Tokyo, Japan
, Shujiro Murata2 Novartis Pharma KK, Minato-ku, Tokyo, Japan
, Tetsuji Kitawaki2 Novartis Pharma KK, Minato-ku, Tokyo, Japan
, Kimitoshi Ikeda2 Novartis Pharma KK, Minato-ku, Tokyo, Japan
& Donald Banerji3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Pages 2543-2551
|
Published online: 11 Oct 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.